(17beta)-17-Hydroxyandrost-4-en-3-one

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

Did a 29 year-old show GlaxoSmithKline that it made a billion dollar mistake?

29 year-old healthcare investor, Vivek Ramaswamy, bought an old Alzheimer's drug that GlaxoSmithKli